Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Neuropsychiatric Systemic Lupus Erythematosus (NPSLE)
100%
Autoantibodies
42%
Systemic Lupus Erythematosus Patient
42%
Recent Advances
28%
Neuroimaging
28%
Neuropsychiatric Manifestations
28%
Healthy Controls
14%
Quality of Life
14%
Attenuation
14%
Diagnostic Methods
14%
Central Nervous System
14%
Targeted Therapy
14%
Objective Diagnosis
14%
Mouse Model
14%
New Evidence
14%
Neuropsychiatric Diseases
14%
Lupus
14%
Systemic Lupus Erythematosus
14%
Cerebrospinal Fluid
14%
Potential Treatments
14%
Cognitive Dysfunction
14%
Potential Biomarkers
14%
Microglia
14%
Neurodegenerative Diseases
14%
Blood-brain Barrier Disruption
14%
Accurate Diagnosis
14%
Patient Prognosis
14%
Anti-NR2
14%
Direct Participation
14%
Life Prognosis
14%
Pathogenic Role
14%
Disease Attenuation
14%
Elevated Levels
14%
Antiribosomal P
14%
Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Pathogenesis
100%
Autoantibodies
30%
Mediator
10%
Targeted Therapy
10%
Blood Brain Barrier
10%
Biological Marker
10%
Cognitive Defect
10%
Cerebrospinal Fluid
10%
Central Nervous System
10%
Degenerative Disease
10%
Quality of Life
10%
Neurodevelopmental Disorder
10%
Lupus Erythematosus
10%
Diseases
10%
Diagnosis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Lupus Erythematosus
100%
Pathogenesis
100%
Autoantibodies
30%
Mouse Model
10%
Biological Marker
10%
Cognitive Defect
10%
Degenerative Disease
10%
Blood-Brain Barrier
10%
Diseases
10%
Mental Diseases
10%
Neuroscience
Systemic Lupus Erythematosus
100%
Autoantibodies
30%
Central Nervous System
10%
Cognitive Disorders
10%
Neurodegenerative Disorder
10%
Lupus Erythematosus
10%
Blood Brain Barrier
10%
Psychopathology
10%
Quality of Life
10%
Biological Marker
10%